Topical and Injected Exosomes

The biology is real

Cells communicate by releasing membrane-bound vesicles carrying proteins, lipids and RNA. Those vesicles change the behavior of the cells that take them up. In laboratory models, preparations derived from mesenchymal stem cells promote fibroblast migration, collagen production and wound closure.

That is a legitimate and active area of research, and it is why this entry says thin evidence and not no.

What is missing

Almost everything that would let anyone grade it higher.

There are very few randomized, controlled human trials of exosome preparations applied to the aging face, and the ones that exist are small, short and usually funded by the product's manufacturer. Split-face designs with blinded assessors are what would settle this, and there are not many.

There is also no standardization. Products sold as exosomes vary enormously in their source tissue, isolation method, particle count, purity and storage. Two clinics can use the word for two preparations with little in common, which makes the literature difficult to pool and makes any individual result hard to generalize.

The regulatory position

This is the part that gets left out of the consultation.

The FDA has stated publicly that there are no approved exosome products for these uses and has issued safety communications after adverse events following administration of unapproved preparations. Products are not being cleared as devices or approved as biologics for facial rejuvenation. A clinic offering them is offering something outside that framework.

That does not automatically make a product unsafe. It does mean that nobody is independently verifying what is in the vial.

Where it might land

The most plausible near-term use is post-procedure recovery, applied topically to skin that has just been resurfaced, where the barrier is open and the mechanism is closest to the biology. If good controlled data arrives for anything, it will probably be that.

The honest summary

Interesting science, marketed years ahead of its evidence, at prices that assume the evidence already exists. If a clinic tells you exosomes will regenerate your skin, a reasonable follow-up is to ask what controlled human data they are relying on and who manufactured the product.